VICKIE L. CAPPS - Corporate Board Profile

AMEDISYS INC

Filing Date	Source Excerpt
2020-04-24	Ms. Capps is also a member of the board of directors, the audit committee chair and a member of the nominating and governance committee of each of NuVasive, Inc., a public medical device company, and Otonomy, Inc., a public biopharmaceutical company. Ms. Capps is also a member of the Board of Directors of OmniGuide, Inc., a private medical device company. ... Ms. Capps earned her bachelors degree from San Diego State University, is a California Certified Public Accountant and was recognized as a CFO of the Year honoree by the San Diego Business Journal in 2009 and 2010. ... The Audit Committee is currently comprised of Jake L. Netterville (Chairman), Mses. Capps and Kline and Messrs. Lechleiter and Washburn. ... The Compensation Committee is currently comprised of Ms. Klapstein (Chair), Mses. Capps and Kline and Messrs. Netterville, Lechleiter and Washburn. ... The Nominating and Corporate Governance Committee is comprised of Richard A. Lechleiter (Chairman) and each of our other independent directors (Mses. Capps, Klapstein and Kline, Messrs. Netterville, Perkins and Washburn, Drs. Coye and Rideout). ... During 2019, all non-employee directors received a monthly retainer of $6,250 and per diem attendance fees of $2,000 per each Board of Directors meeting and each committee meeting attended in person and $1,000 per diem attendance fees for each Board of Directors meeting and each committee meeting attended via teleconference. ... In addition, in connection with the appointments of Vickie L. Capps, Molly J. Coye, MD, and Teresa L. Kline to our Board of Directors effective November 1, 2019, each of Ms. Capps, Dr. Coye and Ms. Kline received an equity grant of 780 shares of nonvested common stock (prorated for their time of service as directors) on November 22, 2019, 100% of which will vest on June 7, 2020, predicated upon each such directors continued service as a non-employee director through the vesting date. ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2019. ... Vickie L. Capps Fees Earned or Paid in Cash: $18,500, Stock Awards: $123,802, Total: $142,302.
2021-04-28	The Audit Committee is currently comprised of Vickie L. Capps (Chair), Teresa L. Kline and Richard A. Lechleiter. ... Ms. Capps earned $256,800 in total compensation in 2020.
2022-04-27	The Audit Committee is currently comprised of Vickie L. Capps (Chair), Teresa L. Kline and Bruce D. Perkins. ... Ms. Capps earned her bachelors degree from San Diego State University, is a California Certified Public Accountant and was recognized as a CFO of the Year honoree by the San Diego Business Journal in 2009 and 2010. ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2021. Vickie L. Capps: Fees Earned or Paid in Cash: $123,500; Stock Awards: $149,992; Total: $273,492.
2023-04-27	The Audit Committee is currently comprised of Vickie L. Capps (Chair), Teresa L. Kline and Bruce D. Perkins. Ms. Capps is a certified public accountant, a former chief financial officer and has been designated as our “Audit Committee Financial Expert” on our Audit Committee. The Compensation Committee is currently comprised of Teresa L. Kline (Chair), Vickie L. Capps, Julie D. Klapstein and Jeffrey A. Rideout, MD. On June 9, 2022, each of Mses. Capps, Kline, Klapstein and Samuels, Drs. Coye and Rideout, and Mr. Perkins received an equity grant of RSUs valued at $150,000 in connection with their re-election as directors at the 2022 annual meeting of stockholders.
2024-12-10	Vickie L. Capps is currently a member of the board of directors and the audit committee chair of each of Janux Therapeutics, Inc., a public, pre-commercial biopharmaceutical company... The Audit Committee is currently comprised of Vickie L. Capps (Chair), Teresa L. Kline and Bruce D. Perkins. ... The following table shows the value of all cash and equity-based compensation paid to the members of our Board of Directors during the year ended December 31, 2023. ... Vickie L. Capps, Fees Earned or Paid in Cash $125,000, Stock Awards $152,621, Total $277,621.